title: Selective inhibition of oncogenic ras-p21 in vivo by agents that block its interaction with jun-N-kinase (JNK) and jun proteins. Implications for the design of selective chemotherapeutic agents.
abstract: We have obtained evidence that oncogenic and activated normal ras-p21 proteins utilize overlapping but distinct signal transduction pathways. Recently, we found that ras-p21 binds to both jun and its kinase, jun kinase (JNK). We now present evidence that suggests that oncogenic but not normal activated p21 depends strongly on early activation of JNK/jun. This early activation most likely involves direct interaction between oncogenic p21 and JNK/jun because p21 peptides that blocked the binding of p21 to JNK and jun strongly inhibited oncogenic p21-induced oocyte maturation while they did not inhibit insulin-activated normal cellular p21-induced maturation. Very similar results were also obtained for a newly characterized specific inhibitor of JNK which blocked oncogenic but not normal activated p21-induced oocyte maturation. We also found that both jun and JNK strongly enhanced oncogenic p21-induced oocyte maturation while they inhibited insulin-activated normal p21-induced oocyte maturation. These results suggest that the peptides and JNK inhibitor may be useful agents in selectively blocking the effects of oncogenic but not normal p21 in cells.
authors.affiliation: Department of Pathology and Laboratory Medicine, Veterans Affairs Medical Center, Brooklyn, NY 11209, USA.
authors.forename: S
authors.initials: S
authors.lastname: Amar
authors.forename: A
authors.initials: A
authors.lastname: Glozman
authors.forename: D
authors.initials: D
authors.lastname: Chung
authors.forename: V
authors.initials: V
authors.lastname: Adler
authors.forename: Z
authors.initials: Z
authors.lastname: Ronai
authors.forename: F K
authors.initials: FK
authors.lastname: Friedman
authors.forename: R
authors.initials: R
authors.lastname: Robinson
authors.forename: P
authors.initials: P
authors.lastname: Brandt-Rauf
authors.forename: Z
authors.initials: Z
authors.lastname: Yamaizumi
authors.forename: M R
authors.initials: MR
authors.lastname: Pincus
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents; D017871:Calcium-Calmodulin-Dependent Protein Kinases / Q000235:genetics; D004926:Escherichia coli / Q000235:genetics; D015870:Gene Expression; D016758:Genes, jun / Q000235:genetics* / Q000502:physiology; D007328:Insulin / Q000502:physiology; D048031:JNK Mitogen-Activated Protein Kinases; D020928:Mitogen-Activated Protein Kinases; D015689:Oncogene Protein p21(ras) / Q000235:genetics* / Q000502:physiology; D009865:Oocytes / Q000254:growth & development; D011485:Protein Binding; D011494:Protein Kinases / Q000235:genetics*; D015398:Signal Transduction / Q000502:physiology*; D014157:Transcription Factors / Q000235:genetics* / Q000502:physiology; D014764:Viral Proteins / Q000235:genetics* / Q000502:physiology; D014982:Xenopus laevis
chemical_list: D000970:Antineoplastic Agents; D007328:Insulin; C073501:Nun protein, Enterobacteria phage HK022; D014157:Transcription Factors; D014764:Viral Proteins; D011494:Protein Kinases; D017871:Calcium-Calmodulin-Dependent Protein Kinases; D048031:JNK Mitogen-Activated Protein Kinases; D020928:Mitogen-Activated Protein Kinases; D015689:Oncogene Protein p21(ras)